Predictors of Long Term Survival in Patients With Cystic Fibrosis Following Lung Transplantation

Lung transplantation (LTX) is the ultimate therapy for end-stage cystic fibrosis (CF) lung disease; however, morbidity and mortality are considerable. CF patients achieve the best overall outcome post LTX. We investigated a subgroup of CF-patients and a minimum of 10 years post-LTX survival, aiming to determine possible predictors of long-term survival and characterize comorbidities.

Source: The Journal of Heart and Lung Transplantation - March 31, 2018 Category: Transplant Surgery Authors: C.A. Robinson, A. Deibel, M.M. Schuurmans, I. Inci, C. Benden Source Type: research